- Healthcare investors see no threat from Supreme Court (reuters.com)
Investors are betting that the healthcare sector's strong run will not be held back for long even if the U.S. Supreme Court rules against the Affordable Care Act. At issue are the tax credits that help about 6.4 million low- and moderate-income Americans buy insurance. If the Court rules against the credits, millions of Americans may find they cannot afford their insurance. This could affect the health insurers as well as hospitals and other providers........
- A HIPAA violation, a $1.8 million verdict, and three takeaways (drugtopics.modernmedicine.com)
The second tenet of the APhA Code of Ethics states, "A pharmacist promotes the good of every patient in a caring, compassionate, and confidential manner." It sounds easy. It evokes an immediate response from each pharmacist and pharmacy technician: "I wouldn’t violate that, no matter what."
- U.S. jury clears Pfizer in second trial alleging Zoloft birth defects (reuters.com)
A U.S. jury on Thursday said Pfizer Inc. was not responsible for birth defects in a young girl whose mother took its antidepressant Zoloft while pregnant, the second straight win for the company out of hundreds of similar lawsuits. Plaintiff Rachel Robinson claimed in her 2011 lawsuit that Pfizer failed to warn that using Zoloft during pregnancy could cause birth defects and sought damages from the company after her now eight-year-old daughter was born with a rare, serious heart problem.